TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TCRX

Tscan Therapeutics Inc

Healthcare · Biotechnology

0.349$ -4.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TCRX
Line item 2019 2020 2021 2022 2023 2024 2025
0.00 0.04 0.42 0.56 0.32 0.03 0.08
0.38 0.83 0.14 0.21 1.34 0.04 0.02
-0.38 -0.78 0.42 0.56 0.32 0.03 0.06
0.38 0.83 1.88 2.49 1.34 0.96 0.88
0.19 0.27 0.58 0.85 0.39 0.26 0.25
0.19 0.27 2.46 3.33 1.75 1.23 1.10
-0.57 -1.05 -2.03 -2.77 -1.42 -1.20 -1.05
0.00 0.00 0.00 0.05 0.06 0.03 0.02
-0.55 -1.05 -2.03 -2.75 -1.36 -1.14 -1.00
-0.02 0.00 0.13 -0.02 0.08 – –
-0.55 -1.05 -2.03 -2.75 -1.36 -1.14 -1.00
-0.55 -1.00 -1.89 -2.49 -1.22 -1.07 -0.96

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?